cytidine has been researched along with Cancer of Prostate in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Gu, X; Li, X; Liu, Y; Song, S; Wang, J; Wang, Z; Xu, B; Yang, Q; Yu, G; Zhan, M | 1 |
| Broggini, M; Ceruti, R; Ganzinelli, M; Geroni, C; Sabatino, MA | 1 |
| Bianco-Miotto, T; Butler, LM; Centenera, MM; Chiam, K; Tilley, WD | 1 |
| Gertych, A; Oh, JH; Tajbakhsh, J; Wawrowsky, KA; Weisenberger, DJ | 1 |
| Chuang, JC; Jones, PA; Kwan, JM; Li, TW; Liang, G; Yang, AS; Yoo, CB | 1 |
| Bova, GS; Brooks, JD; Campbell, PA; Epstein, JI; Hsieh, WS; Isaacs, WB; Lee, WH; Morton, RA; Nelson, WG | 1 |
| Akita, H; Itoh, Y; Kohri, K; Tozawa, K; Ueda, K; Yasui, T | 1 |
| Henrique, R; Jerónimo, C; Lopes, C; Nelson, WG; Oliveira, J; Sidransky, D; Usadel, H | 1 |
8 other study(ies) available for cytidine and Cancer of Prostate
| Article | Year |
|---|---|
Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.
Topics: Cytidine; Genes, Regulator; Humans; Male; Methylation; Prostatic Neoplasms; RNA; Tumor Microenvironment | 2022 |
Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cytidine; DNA Methylation; Gene Expression Regulation, Neoplastic; Glutathione Transferase; Guanidines; Humans; Male; Mice; Prostatic Neoplasms; Pyrroles; Random Allocation; Xenograft Model Antitumor Assays | 2013 |
GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells.
Topics: Azacitidine; Biomarkers, Tumor; Cell Death; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytidine; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Glutathione S-Transferase pi; Humans; Male; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors | 2011 |
3-D DNA methylation phenotypes correlate with cytotoxicity levels in prostate and liver cancer cell models.
Topics: 5-Methylcytosine; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Survival; Cytidine; DNA Methylation; Humans; Liver Neoplasms; Male; Phenotype; Prostatic Neoplasms | 2013 |
Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2'-deoxycytidine.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Transitional Cell; Catechin; Cell Line, Tumor; Colorectal Neoplasms; Cytidine; Decitabine; Deoxycytidine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Silencing; HT29 Cells; Humans; Hydralazine; Male; Procainamide; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction | 2005 |
Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
Topics: Carcinoma; Cytidine; DNA Topoisomerases, Type I; Gene Expression Regulation, Enzymologic; Glutathione Transferase; Humans; Male; Methylation; Prostate; Prostatic Neoplasms; Regulatory Sequences, Nucleic Acid; Restriction Mapping; RNA, Messenger | 1994 |
CAG repeats in the androgen receptor: a case of spinal and bulbar muscular atrophy associated with prostate cancer.
Topics: Adenocarcinoma; Adenosine; Cytidine; Guanosine; Humans; Male; Middle Aged; Muscular Atrophy, Spinal; Prostatic Neoplasms; Receptors, Androgen; Trinucleotide Repeats | 1999 |
Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.
Topics: Adenocarcinoma; Cytidine; DNA Methylation; Fluorescence; Gene Expression; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Isoenzymes; Male; Polymerase Chain Reaction; Promoter Regions, Genetic; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Tumor Cells, Cultured | 2001 |